Generate a tailored SOP for Dr. Robert Reiter. Improve your application with a focused, well-structured draft.
Dr. Robert Reiter is a Professor in the Department of Urology at the University of California, Los Angeles (UCLA). He is also the Director of the UCLA Prostate Cancer Program and Co-Director of the UCLA Urologic Research Program. With extensive expertise in urologic oncology, Dr. Reiter's clinical practice and research focus on prostate cancer and other urologic malignancies. He is heavily involved in clinical trials aimed at improving therapies and outcomes for patients with these conditions. His laboratory is dedicated to the study of molecular biology in urologic cancers, particularly aiming to discover cell surface proteins that are implicated in prostate cancer progression. Dr. Reiter has collaborated on significant research projects, including studies on prostate stem cell antigen (PSCA), and has made critical contributions to the understanding of prostate cancer's biological mechanisms. His work fosters the development of innovative targets for diagnosis and treatment in clinical settings. Dr. Reiter is board certified in Urology and has trained at leading institutions, including Stanford University and the National Cancer Institute.
UCLA • Los Angeles, CA
Leading research and clinical initiatives in urologic oncology.
UCLA Prostate Cancer Program • Los Angeles, CA
Overseeing the prostate cancer treatment program, focusing on innovative therapies.
UCLA Urologic Research • Los Angeles, CA
Co-leading the research program aimed at advancing knowledge and treatment of urologic cancers.
Department of Economics admits primarily for the PhD program.